Natural History Study of Incidence of Otorrhea Following Tympanostomy Tube

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT03347461` - Otiprio Versus Ciprodex Tympanostomy Tube Outcomes	Phase 4
Recruiting	`NCT04807660` - Bacteriological Evaluation of Children With Otorrhea
Withdrawn	`NCT00956748` - N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis Media	Phase 4
Terminated	`NCT02817347` - A Clinical Trial of YH1177 in Patients With Otitis Media and Otorrhea	Phase 1/Phase 2

See also

Status

Clinical Trial

Phase

Withdrawn

NCT03347461 - Otiprio Versus Ciprodex Tympanostomy Tube Outcomes

Phase 4

Recruiting

NCT04807660 - Bacteriological Evaluation of Children With Otorrhea

Withdrawn

NCT00956748 - N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis Media

Phase 4

Terminated

NCT02817347 - A Clinical Trial of YH1177 in Patients With Otitis Media and Otorrhea

Phase 1/Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01111877
Study type	Observational
Source	Alcon Research
Contact
Status	Terminated
Phase	N/A
Start date	May 2010
Completion date	November 2011

Natural History Study of Incidence of Otorrhea Following Tympanostomy Tube Insertion in Children 6 Months to 12 Years

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms